Ortho Dermatologics' Altreno lotion is now approved for the topical treatment of acne vulgaris in patients ages 9 and up. Altreno, containing tretinoin 0.05%, will be available during the fourth quarter of this year. The FDA has accepted Ortho Dermatologics' resubmitted New Drug Application for Duobrii Lotion for the topical treatment of plaque psoriasis. Only 10 percent of patients with psoriasis feel their condition is under control with their current treatment plans, results of the PlaquePsoriasis.com survey "Psoriasis in America 2018" show. Stigmatizing views and myths about psoriasis are pervasive among the general population and medical students in the United States, according to results from multidisciplinary research from the Perelman School of Medicine at the University of Pennsylvania. JW Pharmaceutical and LEO Pharma have signed a global licensing agreement for JW's novel atopic dermatitis drug candidate JW1601.